Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2025-12-31 @ 6:48 AM
Study NCT ID:
NCT05153135
Status:
COMPLETED
Last Update Posted:
2021-12-21
First Post:
2021-11-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-08
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-31
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-29
First Submit QC Date:
None
Study First Post Date:
2021-12-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-15
Last Update Post Date:
2021-12-21
Last Update Post Date Type:
ACTUAL